Technical Analysis for BVNRY - Bavarian Nordic

Grade Last Price % Change Price Change
grade B 8.7 2.47% 0.2100
BVNRY closed up 2.47 percent on Friday, August 30, 2019, on 5.65 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical BVNRY trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Narrow Range Bar Range Contraction 2.47%
Wide Bands Range Expansion 2.47%
Gapped Up Strength 2.47%
Overbought Stochastic Strength 2.47%

Older signals for BVNRY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Bavarian Nordic A/S, a biotechnology company, develops, manufactures, and commercializes a portfolio of novel vaccines for the prevention and treatment of life-threatening infectious diseases and cancer. The company markets non-replicating smallpox vaccine under the IMVAMUN and IMVANE names. It is also developing MVA-BN Filo that is in Phase III trial for the treatment of Ebola and Marburg; MVA-BN RSV, which is in Phase II clinical development stage for the prevention of respiratory syncytial virus; and MVA-BN HPV that is in preclinical development stage to treat human papillomavirus. In addition, the company is developing PROSTVAC, which is in Phase III clinical development for the treatment of asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer; CV301 that is in Phase II clinical trial for the treatment multiple cancers; and MVA-BN Brachyury that has completed Phase I clinical trial for the treatment of metastatic cancer. The company has collaboration agreements with National Cancer Institute; Bristol-Myers Squibb; Janssen Pharmaceuticals, Inc.; Biomedical Advanced Research and Development Authority; US Department of Defense; and PCI Biotech. The company operates in the United States, Holland, Canada, and internationally. Bavarian Nordic A/S was founded in 1994 and is headquartered in Kvistgård, Denmark.
Biotechnology Cancer Clinical Medicine Drugs Life Sciences Infectious Diseases Vaccines Bristol Myers Squibb Cancer Vaccines Hpv Bavarian Nordic Metastatic Cancer Ebola National Cancer Institute Us Department Of Defense Biomedical Advanced Research And Development Authority Company Markets Non Replicating Smallpox Cv301 Ebola Vaccine Minimally Symptomatic Metastatic Castration Resistant Prostate Cancer Prostvac Treatment Multiple Cancers Treatment Of Life Threatening Infectious Diseases Treatment Of Metastatic Cancer
Is BVNRY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 22.7
52 Week Low 5.92
Average Volume 444
200-Day Moving Average 12.2925
50-Day Moving Average 7.3248
20-Day Moving Average 7.6345
10-Day Moving Average 8.338
Average True Range 0.2918
ADX 18.17
+DI 57.2474
-DI 36.6069
Chandelier Exit (Long, 3 ATRs ) 8.1146
Chandelier Exit (Short, 3 ATRs ) 7.2954
Upper Bollinger Band 9.3166
Lower Bollinger Band 5.9524
Percent B (%b) 0.82
BandWidth 44.065754
MACD Line 0.3853
MACD Signal Line 0.2383
MACD Histogram 0.1471
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.7000
Resistance 3 (R3) 8.7000 8.7000 8.7000
Resistance 2 (R2) 8.7000 8.7000 8.7000 8.7000
Resistance 1 (R1) 8.7000 8.7000 8.7000 8.7000 8.7000
Pivot Point 8.7000 8.7000 8.7000 8.7000 8.7000
Support 1 (S1) 8.7000 8.7000 8.7000 8.7000 8.7000
Support 2 (S2) 8.7000 8.7000 8.7000 8.7000
Support 3 (S3) 8.7000 8.7000 8.7000
Support 4 (S4) 8.7000